Gradient Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.8M | Buy |
27,342
+7,757
| +40% | +$7.93M | 0.45% | 68 |
|
|
2026
Q1 | $18M | Sell |
19,585
-884
| -4% | -$896K | 0.28% | 108 |
|
|
2025
Q4 | $22M | Buy |
20,469
+19,634
| +2,351% | +$18.8M | 0.35% | 89 |
|
|
2025
Q3 | $637K | Buy |
835
+166
| +25% | +$124K | 0.01% | 289 |
|
|
2025
Q2 | $522K | Sell |
669
-1
| -0.1% | -$777 | 0.01% | 290 |
|
|
2025
Q1 | $553K | Buy |
670
+298
| +80% | +$248K | 0.01% | 230 |
|
|
2024
Q4 | $287K | Sell |
372
-6
| -2% | -$4.97K | 0.01% | 263 |
|
|
2024
Q3 | $335K | Sell |
378
-135
| -26% | -$121K | 0.01% | 254 |
|
|
2024
Q2 | $464K | Buy |
513
+112
| +28% | +$89.6K | 0.01% | 247 |
|
|
2024
Q1 | $312K | Sell |
401
-497
| -55% | -$354K | 0.01% | 254 |
|
|
2023
Q4 | $523K | Buy |
898
+225
| +33% | +$131K | 0.01% | 247 |
|
|
2023
Q3 | $362K | Sell |
673
-9
| -1% | -$4.64K | 0.01% | 260 |
|
|
2023
Q2 | $320K | Buy |
682
+114
| +20% | +$47.8K | 0.01% | 279 |
|
|
2023
Q1 | $195K | Buy |
568
+89
| +19% | +$30K | 0.01% | 295 |
|
|
2022
Q4 | $175K | Sell |
479
-24
| -5% | -$8.51K | 0.01% | 314 |
|
|
2022
Q3 | $163K | Sell |
503
-658
| -57% | -$208K | 0.01% | 305 |
|
|
2022
Q2 | $376K | Sell |
1,161
-22,018
| -95% | -$6.61M | 0.01% | 249 |
|
|
2022
Q1 | $6.64M | Sell |
23,179
-5,495
| -19% | -$1.41M | 0.17% | 133 |
|
|
2021
Q4 | $7.92M | Sell |
28,674
-1,330
| -4% | -$337K | 0.2% | 126 |
|
|
2021
Q3 | $6.93M | Buy |
30,004
+2,073
| +7% | +$512K | 0.19% | 128 |
|
|
2021
Q2 | $6.41M | Buy |
27,931
+1,926
| +7% | +$387K | 0.19% | 128 |
|
|
2021
Q1 | $4.86M | Sell |
26,005
-56,975
| -69% | -$11.1M | 0.16% | 134 |
|
|
2020
Q4 | $12.3M | Sell |
82,980
-1,003
| -1% | -$150K | 0.52% | 49 |
|
|
2020
Q3 | $12.4M | Buy |
83,983
+25,503
| +44% | +$3.95M | 0.52% | 49 |
|
|
2020
Q2 | $9.6M | Sell |
58,480
-16,051
| -22% | -$2.46M | 0.44% | 66 |
|
|
2020
Q1 | $10.3M | Sell |
74,531
-8,217
| -10% | -$1.13M | 0.56% | 44 |
|
|
2019
Q4 | $10.9M | Buy |
82,748
+1,878
| +2% | +$218K | 0.48% | 55 |
|
|
2019
Q3 | $9.04M | Sell |
80,870
-8,236
| -9% | -$917K | 0.44% | 66 |
|
|
2019
Q2 | $9.87M | Buy |
89,106
+86,488
| +3,304% | +$10.2M | 0.51% | 41 |
|
|
2019
Q1 | $340K | Buy |
2,618
+1,881
| +255% | +$229K | 0.02% | 209 |
|
|
2018
Q4 | $85K | Sell |
737
-184
| -20% | -$20.6K | 0.01% | 279 |
|
|
2018
Q3 | $99K | Hold |
921
| – | – | 0.01% | 283 |
|
|
2018
Q2 | $79K | Sell |
921
-12
| -1% | -$986 | ﹤0.01% | 287 |
|
|
2018
Q1 | $72K | Sell |
933
-292
| -24% | -$23.5K | ﹤0.01% | 299 |
|
|
2017
Q4 | $103K | Buy |
+1,225
| New | +$104K | 0.01% | 279 |
|
|
2017
Q3 | – | Sell |
-1,147
| Closed | -$94K | – | 505 |
|
|
2017
Q2 | $94K | Sell |
1,147
-84,195
| -99% | -$6.87M | 0.01% | 260 |
|
|
2017
Q1 | $7.18M | Buy |
85,342
+6,523
| +8% | +$522K | 0.55% | 28 |
|
|
2016
Q4 | $5.8M | Buy |
78,819
+78,360
| +17,072% | +$5.84M | 0.51% | 40 |
|
|
2016
Q3 | $37K | Hold |
459
| – | – | ﹤0.01% | 280 |
|
|
2016
Q2 | $36K | Buy |
459
+75
| +20% | +$5.65K | ﹤0.01% | 283 |
|
|
2016
Q1 | $28K | Hold |
384
| – | – | ﹤0.01% | 311 |
|
|
2015
Q4 | $32K | Sell |
384
-2
| -0.5% | -$166 | ﹤0.01% | 284 |
|
|
2015
Q3 | $32K | Sell |
386
-44
| -10% | -$3.71K | ﹤0.01% | 266 |
|
|
2015
Q2 | $36K | Buy |
430
+53
| +14% | +$4.04K | ﹤0.01% | 268 |
|
|
2015
Q1 | $27K | Hold |
377
| – | – | ﹤0.01% | 302 |
|
|
2014
Q4 | $26K | Hold |
377
| – | – | ﹤0.01% | 289 |
|
|
2014
Q3 | $24K | Hold |
377
| – | – | ﹤0.01% | 264 |
|
|
2014
Q2 | $23K | Sell |
377
-416
| -52% | -$24.8K | ﹤0.01% | 277 |
|
|
2014
Q1 | $47K | Buy |
793
+96
| +14% | +$5.36K | 0.01% | 207 |
|
|
2013
Q4 | $36K | Sell |
697
-26,973
| -97% | -$1.35M | 0.01% | 254 |
|
|
2013
Q3 | $1.39M | Buy |
27,670
+27,203
| +5,825% | +$1.42M | 0.44% | 70 |
|
|
2013
Q2 | $23K | Buy |
+467
| New | +$25.4K | 0.01% | 218 |
|
Other funds holding LLY
SC
ONB
GIM
Gradient Investments's LLY Position: Q2 2026 in Review
Gradient Investments increased its Eli Lilly (LLY) stake by 40% in Q2 2026, buying an estimated $7.93M and bringing the position to 27,342 shares worth $32.8M. The position accounts for 0.45% of the portfolio, ranked #68.
Gradient Investments first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Gradient Investments held 27,342 shares of Eli Lilly worth $32.8M as of Q2 2026.
- Gradient Investments bought 7,757 Eli Lilly shares in Q2 2026, an estimated $7.93M.
- Eli Lilly made up 0.45% of Gradient Investments's portfolio in Q2 2026, its #68 holding.
- Gradient Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Gradient Investments's 13F filing for Q2 2026, filed 8 Jul 2026.